Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 5/20 | 0.57 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.57 |
| ▸ | KDM1A | O60341 | 4/20 | 0.48 |
| ▸ | CHRM2 | P08172 | 4/20 | 0.46 |
| ▸ | HTR1A | P08908 | 4/20 | 0.46 |
| ▸ | ADRA2A | P08913 | 4/20 | 0.46 |
| ▸ | CHRM1 | P11229 | 4/20 | 0.46 |
| ▸ | DRD1 | P21728 | 4/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 4/20 | 0.46 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.46 |
| ▸ | ADRA1A | P35348 | 4/20 | 0.46 |
| ▸ | OPRM1 | P35372 | 4/20 | 0.46 |
| ▸ | DRD3 | P35462 | 4/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.46 |
| ▸ | LMNA | P02545 | 4/20 | 0.46 |
| ▸ | SLC22A1 | O15245 | 3/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.46 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5000805 | 0.74 | CYP2D6 (0.65) | CYP2D6CYP2C19CYP3A4KDM1ACHRM2 | |
| SCHEMBL8019998 | 0.69 | CYP2D6 (0.67) | CYP2D6CYP2C19CYP3A4KDM1ACHRM2 | |
| SCHEMBL2561326 | 0.69 | CYP3A4 (0.30) | CYP2D6CYP2C19CYP3A4 | |
| SCHEMBL30058159 | 0.69 | LMNA (0.62) | CYP2D6CYP2C19CYP3A4KDM1ACHRM2 | |
| SCHEMBL2595053 | 0.69 | LMNA (0.62) | CYP2D6CYP2C19CYP3A4KDM1ACHRM2 | |
| SCHEMBL18550493 | 0.68 | CYP2D6 (0.56) | CYP2D6CYP2C19CYP3A4KDM1ACHRM2 | |
| SCHEMBL9611564 | 0.68 | KDM1A (0.68) | CYP2D6CYP2C19CYP3A4KDM1ACHRM2 | |
| SCHEMBL27935720 | 0.67 | KDM1A (0.57) | CYP2D6CYP2C19CYP3A4KDM1ACHRM2 | |
| SCHEMBL2595919 | 0.66 | PIM1 (0.66) | CYP2D6CYP2C19CYP3A4KDM1ACHRM2 | |
| SCHEMBL30216959 | 0.66 | PIM1 (0.66) | CYP2D6CYP2C19CYP3A4KDM1ACHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 129 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2014186623-A2 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF A CHAGAS DISEASE | BIOMED VALLEY DISCOVERIES (US) | 2014-11-20 | — | — | WO | claimed |
| WO-2010080577-A2 | OXEPINE MODULATORS OF H1 RECEPTORS AND/OR INHIBITORS OF MAST CELL DEGRANULATION | AUSPEX PHARMACEUTICAL, INC. (US) | 2010-07-15 | — | — | WO | claimed |
| WO-2010075090-A2 | SCOPINE MODULATORS OF MUSCARINIC ACETYLCHOLINE RECEPTOR | AUSPEX PHARMACEUTICALS, INC. (US) | 2010-07-01 | — | — | WO | claimed |
| US-20100160272-A1 | OXEPINE MODULATORS OF H1 RECEPTORS AND/OR INHIBITORS OF MAST CELL DEGRANULATION | AUSPEX PHARMACEUTICALS, INC. (US) | 2010-06-24 | — | — | US | claimed |
| US-20100160271-A1 | BICYCLIC MODULATORS OF H1 RECEPTORS | AUSPEX PHARMACEUTICALS, INC. (US) | 2010-06-24 | — | — | US | claimed |
| US-20100160347-A1 | PYRIDO[1,2-a]PYRIMIDIN-4-ONE INHIBITORS OF MAST CELL DEGRANULATION | AUSPEX PHARMACEUTICALS, INC. (US) | 2010-06-24 | — | — | US | claimed |
| US-20100152224-A1 | SCOPINE MODULATORS OF MUSCARINIC ACETYLCHOLINE RECEPTOR | AUSPEX PHARMACEUTICALS, INC. (US) | 2010-06-17 | — | — | US | claimed |
| US-20100135956-A1 | STEROID MODULATORS OF PROGESTERONE RECEPTOR AND/OR GLUCOCORTICOID RECEPTOR | AUSPEX PHARMACEUTICALS, INC. (US) | 2010-06-03 | — | — | US | claimed |
| US-20100137268-A1 | PHTHALAZINONE MODULATORS OF H1 RECEPTORS AND/OR LTC4 RECEPTORS | AUSPEX PHARMACEUTICALS, INC. (US) | 2010-06-03 | — | — | US | claimed |
| WO-2010054158-A2 | STEROID MODULATORS OF GLUCOCORTICOID RECEPTOR | AUSPEX PHARMACEUTICALS, INC. (US) | 2010-05-14 | — | — | WO | claimed |
| US-20100120733-A1 | STEROID MODULATORS OF GLUCOCORTICOID RECEPTOR | AUSPEX PHARMACEUTICALS, INC. (US) | 2010-05-13 | — | — | US | claimed |
| US-20100113431-A1 | N-METHYL PIPERAZINE MODULATORS OF H1 RECEPTOR | AUSPEX PHARMACEUTICALS, INC. (US) | 2010-05-06 | — | — | US | claimed |
| US-20100087455-A1 | SUBSTITUTED XANTHINE COMPOUNDS | AUSPEX PHARMACEUTICALS, INC. (US) | 2010-04-08 | — | — | US | claimed |
| EP-2170825-A2 | SUBSTITUTED INDOLES | Auspex Pharmaceuticals, Inc. (US) | 2010-04-07 | — | — | EP | claimed |
| US-20090191183-A1 | SUBSTITUTED INDOLES | AUSPEX PHARMACEUTICALS, INC. (US) | 2009-07-30 | — | — | US | claimed |
| WO-2009089234-A2 | SUBSTITUTED DIBENZHYDRYLPIPERAZINES | AUSPEX PHARMACEUTICALS (US) | 2009-07-16 | — | — | WO | claimed |
| US-20090176792-A1 | SUBSTITUTED DIBENZHYDRYLPIPERAZINES | AUSPEX PHARMACEUTICALS, INC. (US) | 2009-07-09 | — | — | US | claimed |
| WO-2009018280-A2 | SUBSTITUTED INDOLES | AUSPEX PHARAMACEUTICALS, INC. (US) | 2009-02-05 | — | — | WO | claimed |
| EP-4406605-B1 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING AND PREVENTING ACUTE RESPIRATORY DISTRESS SYNDROME ASSOCIATED WITH VIRAL INFECTIONS | HISTA RX LLC (US) | 2026-02-04 | — | — | EP | disclosed |
| US-20020193371-A1 | Drugs which can be used in the treatment of cancer | MOLECULAR ENGINES LABORATORIES (FR) | 2002-12-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100152224-A1 | SCOPINE MODULATORS OF MUSCARINIC ACETYLCHOLINE RECEPTOR | CHRM3, CHRM5, CHRM2 | CYP2D6 1599/4885CYP2C19 1295/4885CYP3A4 904/4885 |
| US-20100087455-A1 | SUBSTITUTED XANTHINE COMPOUNDS | XDH, HPRT1, SLC10A1 | CYP2D6 111/4885CYP2C19 115/4885CYP3A4 78/4885 |
| US-20100120733-A1 | STEROID MODULATORS OF GLUCOCORTICOID RECEPTOR | NR3C1, NR3C2, NR5A1 | CYP2D6 891/4885CYP2C19 610/4885CYP3A4 446/4885 |
| US-20100113431-A1 | N-METHYL PIPERAZINE MODULATORS OF H1 RECEPTOR | HRH4, HRH2, HRH3 | CYP2D6 1599/4885CYP2C19 1394/4885CYP3A4 1629/4885 |
| US-20100160272-A1 | OXEPINE MODULATORS OF H1 RECEPTORS AND/OR INHIBITORS OF MAST CELL DEGRANULATION | HRH4, HRH2, HRH3 | CYP2D6 1668/4885CYP2C19 604/4885CYP3A4 1519/4885 |
| US-20100160347-A1 | PYRIDO[1,2-a]PYRIMIDIN-4-ONE INHIBITORS OF MAST CELL DEGRANULATION | CMA1, CPA3, KIT | CYP2D6 1770/4885CYP2C19 522/4885CYP3A4 1351/4885 |
| US-20090191183-A1 | SUBSTITUTED INDOLES | CYSLTR1, LTB4R, LTB4R2 | CYP2D6 372/4885CYP2C19 142/4885CYP3A4 359/4885 |
| US-20100137268-A1 | PHTHALAZINONE MODULATORS OF H1 RECEPTORS AND/OR LTC4 RECEPTORS | HRH4, HRH2, LTB4R | CYP2D6 1682/4885CYP2C19 1134/4885CYP3A4 911/4885 |
| US-20090176792-A1 | SUBSTITUTED DIBENZHYDRYLPIPERAZINES | HRH2, HRH4, HRH1 | CYP2D6 618/4885CYP2C19 729/4885CYP3A4 745/4885 |
| US-20100160271-A1 | BICYCLIC MODULATORS OF H1 RECEPTORS | HRH2, HRH4, HRH1 | CYP2D6 703/4885CYP2C19 582/4885CYP3A4 662/4885 |
| US-20100135956-A1 | STEROID MODULATORS OF PROGESTERONE RECEPTOR AND/OR GLUCOCORTICOID RECEPTOR | NR3C2, PGR, NR3C1 | CYP2D6 573/4885CYP2C19 254/4885CYP3A4 298/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.